Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine.
Journal: Journal of cellular and molecular medicine
Published: January 15, 2013
Showing 1-2 of 2
Last Updated: 09/26/2026